267 - 2022 IDSA Guideline Update

Saturday, October 22, 2022

3:15 PM – 4:30 PM US ET

Location: 150 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Nilesh Hingarh, MD

Physician
Private Practice
Santa Clarita, CA, United States

Disclosure(s): AbbVie Inc: Honoraria (Ongoing)
Cornelius Clancy, MD

Associate Professor of Medicine
Medicine
University of Pittsburgh
Pittsburgh, Pennsylvania, United States

Disclosure(s): receives research funding paid to his institution from Astellas and Merck: Grant/Research Support (); serves as an advisory Board member for Astellas, Cidara, and Scynexis, served on the advisory board for Merck, Qpex Biopharma, and Shionogi: Advisor/Consultant (); Venatorx and Needham & Associates: Advisor/Consultant ()

Faculty(s)

Robert Bonomo, MD

Associate Chief of Staff for Academic Affairs
Division of Medicine
Case Western Reserve University/ Louis Stokes Cleveland VA Medical Center
Cleveland, OH, United States

Disclosure(s): Entasis Pharmaceuticals: Grant/Research Support (Ongoing); Merck: Grant/Research Support (Ongoing); NIH VA: Grant/Research Support (Ongoing); VenatoRx Merck Wockhardt Cystic Fibrosis Foundation: Grant/Research Support (Ongoing); Wockhardt: Grant/Research Support (Ongoing)

Slides
Pranita Tamma, MD, MHS

Associate Professor
Johns Hopkins School of Medicine
Baltimore, Maryland, United States

Disclosure(s): No financial relationships to disclose

Slides

Disclosure(s):

Nilesh H. Hingarh, MD: AbbVie Inc: Honoraria (Ongoing)

Cornelius J. Clancy, MD: receives research funding paid to his institution from Astellas and Merck: Grant/Research Support (); serves as an advisory Board member for Astellas, Cidara, and Scynexis, served on the advisory board for Merck, Qpex Biopharma, and Shionogi: Advisor/Consultant (); Venatorx and Needham & Associates: Advisor/Consultant ()

Robert A. Bonomo, MD: Entasis Pharmaceuticals: Grant/Research Support (Ongoing); Merck: Grant/Research Support (Ongoing); NIH VA: Grant/Research Support (Ongoing); VenatoRx Merck Wockhardt Cystic Fibrosis Foundation: Grant/Research Support (Ongoing); Wockhardt: Grant/Research Support (Ongoing)

Pranita Tamma, MD, MHS: No financial relationships to disclose

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe and apply the latest guidance on the treatment of multidrug-resistant infections;
know and apply the latest guidance on the evaluation and treatment of intra-abdominal infections;

Presentations:

3:15 PM – 3:53 PM US ET

Intra-Abdominal Infections
Speaker: Robert A. Bonomo, MD – Case Western Reserve University/ Louis Stokes Cleveland VA Medical Center
3:53 PM – 4:30 PM US ET

IDSA Guidance on the Treatment of Antimicrobial-Resistant Infections
Speaker: Pranita Tamma, MD, MHS – Johns Hopkins School of Medicine